Sunday, February 25, 2018
 
 
Company News: Page (1) of 1 - 01/22/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Agenus Announces Combination Clinical Trials of its Anti-CTLA4 (AGEN1884) & Anti-PD1 (AGEN2034)
- Combination trial accrual completed in first cohort of patients- Commercial grade AGEN1884 and AGEN2034 to be available by mid-year- Non-exclusive access to partners for clinical and commercial supp...
(January 22, 2018)
This article is no longer available,but here are some related topics.


Page: 1


Related Keywords: Inc.,Science,Medical,Biology,Cancer,Other,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines